Abstract:Background: Chemotherapy drugs especially anthracyclines are widely used in the treatment of hematological malignancies and solid tumors. However, their clinical application is limited by dose-dependent and irreversible heart injury, which increases the risk of congestive heart failure and heart-related mortality.Purpose: This study aims to investigate the effect and mechanism of the natural flavonoid isoorientin (ISO) combined with doxorubicin (DOX) on the proliferation of tumor cells and improve the survival rate of DOX-injured cardiomyocytes.Study design/methods: Cardiomyocyte H9c2 and a variety of tumor cells were used to evaluate the protective effect of ISO on DOX-induced myocardial injury and enhance the anticancer effects of DOX. DOX chemotherapy-injured mice were used to evaluate the cardioprotective effect of ISO.Results: The antiproliferation of DOX on Hela, HepG2, HT-29, and A549 cells could be increased synergistically when cotreated with ISO in vitro. ISO could also improve the survival rate of DOX-injured cardiomyocytes by reducing reactive oxygen species, maintaining mitochondrial function, and inhibiting apoptosis. In mice receiving DOX, a protective effect on myocardial tissue, which was reflected by improved survival state of mice receiving chemotherapy, was observed. The ECG, myocardial zymogram data, HE staining, and TEM observation of myocardial tissue sections showed that ISO had a dose-dependent protective effect on the mouse hearts injured by DOX. Network pharmacology and cardiomyocyte proteomics were used to seek for related target proteins to reveal the protective mechanism of ISO on mouse models, and some potential targets (including caspase-3, EGFR, MAPK1, ESR1, CDC42, STAT1, JAK2, LCK, and CDK2) were generated. Western blotting was further used to verify that ISO upregulated Nrf2 and TGF-83 by downregulating the phosphorylation levels of JNK and p38 proteins on the MAPK pathway and the Akt and Stat3 expression levels. The downregulation of cleaved caspase-3 and upregulation of Bcl-xl by ISO further confirmed its inhibition on caspase-dependent cardiomyocyte apoptosis.Conclusion: ISO could be a potential synergistic anticancer agent with a favorable property of reducing the cardiotoxicity for DOX, and the effect mechanism could refer to the inhibition of ISO on MAPK and caspase-dependent apoptosis pathways.

Effect of Isoorientin on Intracellular Antioxidant Defence Mechanisms in Hepatoma and Liver Cell Lines

Isoorientin protects BRL-3A rat liver cell against hydrogen peroxide-induced apoptosis by inhibiting mitochondrial dysfunction, inactivating MAPKs, activating Akt and scavenging ROS and NO

Isoorientin Induces Apoptosis Through Mitochondrial Dysfunction and Inhibition of PI3K/Akt Signaling Pathway in HepG2 Cancer Cells

Isoorientin Prevents Hyperlipidemia and Liver Injury by Regulating Lipid Metabolism, Antioxidant Capability, and Inflammatory Cytokine Release in High-Fructose-Fed Mice.

Isoorientin Attenuates Benzo[a]pyrene-Induced Liver Injury by Inhibiting Autophagy and Pyroptosis in Vitro and Vivo

[Resveratrol Protects Against Hydrogen Peroxide Induced Injury in Human Umbilical Vein Endothelial Cells].

Isoorientin Attenuated the Pyroptotic Hepatocyte Damage Induced by Benzo[a]pyrene via ROS/NF-κB/NLRP3/Caspase-1 Signaling Pathway

Effects of Natural Flavonoid Isoorientin on Growth Performance and Gut Microbiota of Mice.

Isoorientin Attenuates Lipopolysaccharide-Induced Pro-Inflammatory Responses Through Down-Regulation of ROS-related MAPK/NF-κB Signaling Pathway in BV-2 Microglia

Isosinensetin alleviates the injury of human bronchial epithelial cells induced by PM2.5.

Anti-proliferation effects of isorhamnetin on lung cancer cells in vitro and in vivo

Protective Effect of Isoorientin on Oleic Acid-Induced Oxidative Damage and Steatosis in Rat Liver Cells

Isoorientin attenuates benzo[a]pyrene-induced colonic injury and gut microbiota disorders in mice

Isoorientin Attenuated The Pyroptotic Hepatocyte Damage Induced By Benzo[A]Pyrene Via Ros/Nf-Kappa B/Nlrp3/Caspase-1 Signaling Pathway

Network pharmacology analysis and experimental verification of the antitumor effect and molecular mechanism of isocryptomerin on HepG2 cells

Isoquercitrin induces apoptosis and autophagy in hepatocellular carcinoma cells via AMPK/mTOR/p70S6K signaling pathway

Isoorientin induces apoptosis and autophagy simultaneously by reactive oxygen species (ROS)-related p53, PI3K/Akt, JNK, and p38 signaling pathways in HepG2 cancer cells.

Isoorientin Ameliorates APAP-Induced Hepatotoxicity via Activation Nrf2 Antioxidative Pathway: The Involvement of AMPK/Akt/GSK3β

Isoorientin Attenuates Doxorubicin-Induced Cardiac Injury Via the Activation of MAPK, Akt, and Caspase-dependent Signaling Pathways.

MAPK Signaling Pathways Regulate Mitochondrial-Mediated Apoptosis Induced by Isoorientin in Human Hepatoblastoma Cancer Cells.

Isoorientin ameliorates H2O2-induced apoptosis and oxidative stress in chondrocytes by regulating MAPK and PI3K/Akt pathways